NCT02101853 2025-12-01Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting669 enrolled 14 charts
NCT00671034 2021-04-27Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaChildren's Oncology GroupPhase 3 Completed166 enrolled 18 charts